___A
Salmonella typhi Vi antigen in addition to S. typhi 0 antigens 9 and 12. and a mouse-virulent S. typhimurium hybrid (HI). which expresses only the 9 and 12 antigens of S. typhi, were compared in their behavior as challenge organisms in a system developed to assay the protective capabilities of typhoid vaccines. SwissWebster white mice, vaccinated intraperitoneally with live Escherichia coli hybrids expressing the S. typhi 0 antigens 9 and 12, were significantly protected against death from intraperitoneal challenge with each of the S. tvphirnurittm hybrid strains. Vaccination with an E. coli hybrid expressing the S. tvphi Vi antigen in addition to 0 antigens 9 and 12 was seen to confer no advantage in protection against either S. typhimttrium hybrid challenge organism over that obtained by vaccination with an E. coli hybrid expressing only the 0 antigens of S. tvphi. However, a notable difference in the behavior of the two S. tvphimuritam hybrids was seen in mice vaccinated with the parent of the E. co/i hybrid vaccinating strains, E. coli F464, which expresses no surface antigens common to either of these S. typhimturium hybrid challenge organisms. A nonspecific (with respect to the vaccinating strain) protective effect, believed to be associated with Vi antigen expression by the challenge organism, was seen against the challenge with S. typhimttrium hybrid H42 after F464 vaccination, whereas no protection was conferred by F464 vaccination against the challenge with Vi-nonexpressing S. typhimurium hybrid HI. Inasmuch as neither S. typhimuriutm hybrid discriminates between the expression or nonexpression of the Vi antigen in a vaccinating strain. it is concluded that the Vi-nonexpressing S. typhinturium hybrid Hi, which more clearly indicates the vaccine-specific protective role of the S. typhi 0 antigens and does not exhibit the nonspecific protection response of hybrid H42, is the better I choice as challenge organism for this vaccine assay system.
In previous studies (1-5) aimed at developing of these studies which suggest that an S. rvphian animal protection system suitable for the murium hybrid expressing only the 0 antigens of assay of vaccines against typhoid feve" in hu-S. tvphi might be more suitable for this purpose mans, we have examined the feasibilit) of using than hybrid H42. mouse-virulent Salmonella typhimurium hybrids
In an earlier study (1), we conducted experiexpressing Salmonella typhi surface antigens as ments in which S. typhimurium hybrids, exchallenge organisms in vaccinated Swiss-Webpressing different combinations of S. tVphi-dester white mice. Our initial expectation was that rived surface antigens, were used as challenge the ideal hybrid for this purpose would be one organisms in mice immunized with nonliving expressing a complete set of these S. typhi-vaccines prepared from strains of S. typhimur-L46J derived antigens, i.e., the 0 antigens 9 and 12.
ium, S. typhi, and S. typhimurium hybrids that .... a hybrid is S. typhimurium H42. and, indeed, results of these experiments indicated that the 4 this strain has been employed as a challenge immune response generated against the 0 surorganism in every one of our previous studies face antigens of the challenge organism is an :
• with this assay system (1) (2) (3) (4) (5) Animal Resources, National Research Council.) The characteristics in a manner which adversely animals tolerated this vaccinating dose well with all of affects its ability to respond properly as a chalthe immunizing strains employed, and deaths resulting lenge organism, with the result that some vacfrom toxemia seldom occurred. Mice were challenged cines protect nonspecifically against such hy-5 weeks later with 2,500 organisms (in 0.5 ml) of S. brids (1) . An especially disturbing example of typhimurium hybrid H42 or S. typhimuriunI hybrid HI this nonspecific protective effect was seen in our administered intraperitoneally. Survivors were counted 21 days after challenge. most recent study (3) . in which mice vaccinated Test for statistical significance. The results of the with the Escherichia coli strain F464, which assays were analyzed as RXC tables by using the usual expresses no surface antigens common to S.
chi-square criterion (15). typhimurium hybrid H42, were significantly protected against death after challenge with that RESULTS hybrid. In view of these findings, a reconsideration of the merit of using hybrid H42 as a S. typhimurium hybrid H42, expressing the S. challenge organism in this system seemed in typhi surface antigens 9, 12. d. and Vi, has been order. In the present communication, we comused previously as a challenge organism in testpare the behavior of S. typhimurium hybrid H42 ing the live vaccinating strains E. coli hybrid as a challenge organism with that of S. typhimur-F1061, E. coli hybrid WR3078, and their parent, turm hybrid HI, which expresses only the 0 E. coil F464 (3); its response to those strains in surface antigens of S. typhi, and we argue that the present study was similar to that which we hybrid HI is the better choice for vaccine assay.
observed in the earlier study. S. typhimuriurn hybrid HI, which expresses only the 9 and 12 0 MATERIALS AND METHODS surface antigens of S. typhi. has not been emBacterial strains. The male parent of all of the ployed previously as a challenge organism with hybrids employed in this study is S. typhi WR4000 any of the live vaccinating strains examined (serotype 09, 12-Vi: d), originally designated TD-7.
here. The comparison of the behavior of hybrid an Hfr strain whose derivation and description were Hi with that of hybrid H42. as challenge orgareported previously (8). Kiefer et al. (10) described the nisms in protection experiments with five live generation of E. coli hybrid F1061 from the mating vaccinating strains, is shown in Table 1 . between S. typhi WR4000 and E. coli F464 (serotype The notable difference in the behavior of the 08: K : H ) as the consequence of recombination at the rfb loci. E. coli hybrid F1061 expresses the S. typhi two S. typhimurium hybrid challenge organisms 0 antigens 9 and 12 and lacks the 08 specificity of its was seen in those mice vaccinated with the live E. coli parent F464. E. coli hybrid WR3078 was E. coli strain F464. The nonspecific (with rederived from E. coli hybrid F1061 by transfer of the Vi spect to the vaccinating strain) protective effect antigen-determining (viaB+) genes from S. tvphi against hybrid H42 resulted in the survival of WR4000 (3): E. coli hybrid WR3078 expresses the S. 50% of the F464-vaccinated animals challenged typhi Vi antigen in addition to S. tvphi 0 antigens 9 and with this hybrid, which is a significant level of 12. The S. typhimurium hybrid challenge organisms protection (P < 0.005). In contrast, similarly HI and H42, originally referred to as WR5004 His*. 9 P464-vaccinated mice were not protected when 12: i-I. 2 and W R5004 His', Ara'-2. 9, 12, Vi: d-I .2.
1 tvph imuriu m ice w as empro yed w hen respectively, were derived from the mouse-virulent S.
S. tvphimurium hybrid HI was employed as the typhimurium strain WR5004 by mating with S. yvphi challenge or-anis•l. WR4000. as described in a previous communication E. coli hybrids expressing S. typhi 0 antigen (2). S. typhimurium hybrid H42 expresses the S. typhi specificity have been suggested as possible can-0 antigens 9 and 12, the S. typhi Vi antigen, and the S. didates for use in human subjects to develop a safe, orally administered, vaccine for the preed or indicated in our earlier studies with this vention of typhoid fever (10). Vaccination here system. First. the immune response directed with either of the F464-derived live E. coli against the S. typhi 0 antigens expressed by an hybrids F1061 (expressing the S. typhi 0 anti-S. typhimuriutn hybrid challenge organism is gens 9 and 12) or WR3078 (expressing the S. important in protecting the animals against death tvphi 0 antigens 9 and 12 and the Vi antigen)
(1). Second, this 0 antigen-specific protective conferred significant protection against both S. effect is seen more clearly when a Vi-negative typhimuriurn hybrid challenge organisms. With hybrid is employed as the challenge organism hybrid HI as the challenge organism, the protecthan when a Vi-positive hybrid is used (1. 2). tion resulting from S. typhi 0 antigen expression Third. the presence of the Vi antigen in the by the E. colt hybrid vaccinating strains was vaccine or vaccinating strain does not contribute readily apparent when viewed in comparison in any observable manner to the protection with the absence of protection against Hi in the conferred against a Vi-positive S. typhimurium animals vaccinated with the E. colt parent strain hybrid challenge organism (1, 3-5). In addition. F464. However, with H42 as the challenge orgathe present findings show that the nonspecific nism, the influence of the S. typhi 0 antigens in protective effect that vaccination with E. colt those E. colt hybrid vaccinating strains was F464 engenders against a challenge with S. t "ylargely obscured by the nonspecific protective phimurium hybrid H42 (an effect that we believe effect against hybrid H42. Vaccination with the is associated with Vi antigen expression by H42) Vi antigen-expressing (Vi-positive) E. colt hydoes not occur when the Vi-negative S. typhibrid WR3078 was seen to confer no protection murium hybrid HI is employed in this manner. advantage over vaccination with the Vi-nonexIn our early studies with this system (1, 2; pressing (Vi-negative) E. coli hybrid F1061 B. B. Diena, unpublished data), we noted that against a challenge with either of the S. typhi-all S. typhimurium hybrids that had inherited murium hybrids. The best protection against and expressed the S. typhi Vi antigen-determinboth challenge organisms was conferred by vacing genes were, when used as challenge orgacination with the live S. typhi strains Ty2 and the nisms, better protected against by most of the Vi-negative Ty2W. The level of protection convaccines we tested, irrespective of the specificferred against HI by these strains was about the ity of the vaccines for their surface antigens, same as that conferred against H42. and there than were S. typhimurium hybrids that had not was no essential difference between Ty2 and inherited the Vi-determining genes. Because the Ty2W in the protection conferred againqt either inheritance of unlinked, unselected characters in hybrid challenge organism. the S. typhi x S. typhimurium mating system is very low (9), we assumed this nonspecific pro-DISCUSSION tective effect to be due to Vi antigen expression
The results of the present study indicate and in these hybrids rather than to their inheritance reinforce several points that have been suggestof other relevant but undetected S. ty phi charac- ters, although the latter possibility has not been gens, as challenge organisms in the present ruled out. In examining the virulence of S. system, has provided a different answer to the tvphimurium WR5004 and its S. typhi surface question of which S. typhi antigens are imporantigen-expressing hybrid derivatives adminis-tant in mouse protection than has the use of tered intraperitoneally at low dose levels, it was mucin-treated S. typhi as the challenge orgaobserved that all of the Vi-positive hybrids were nism. In the latter system, which is currently measurably slower (2 to 3 days) in bringing employed as a laboratory assay for typhoid about the onset of deaths in nonimmunized mice vaccines, the protective role of the Vi antigen thaii were S. typhimurium WR5004 and Vi-has been well documented (11. 14. 19). Howevnegative hybrids of this strain (1: B. B. Diena, er, neither the importance of the Vi antigen in unpublished data). We also noted in the present mouse protection in that system nor its lack of study, this 2-to 3-day delay in the onset of involvement in protection in ours provides a mouse deaths in the nonvaccinated control convincing indication of the role of this antigen group challenged with S. tvphimurium hybrid in human protection. As we have frequently H42. Earlier (1), we speculated that this altered stated, evidence for the role of any antigen in virulence pattern might be a factor in the protecprotection against typhoid fever in humans must tive effect of nonspecific vaccination against come from studies conducted with human subthese Vi-positive hybrid challenge strains. At jects. Accordingly, the desired assay system is the present time, however, we are still not able one in which the laboratory test results are in to provide a fully satisfactory explanation for agreement with the findings of human experithis effect. Nevertheless, we consider the proence. tection conferred against S. typhirnurium hybrid Although it has long been assumed by many H42 by vaccination with E. coil F464, which workers that the Vi antigen is important in the expresses no surface antigens common to that protective immunization of humans against tyhybrid, to be an improper response for a system phoid fever, there has never been, to our knowlintended to differentiate vaccines on the basis of edge, any experimental evidence, either from their antigenic specificity and to reflect their field trials or volunteer studies, to support this potential as immunizing agents against typhoid belief. On the other hand, studies in recent years fever in humans. The use of S. typhimuriutm with the attenuated S. ty'phi galE mutant Ty2la hybrid HI in the present comparison provides (6, 7, 17, 18) have shown that effective human what we consider a more appropriate response, typhoid protection can be achieved by an immui.e., no significant protection is conferred by E.
nization in which the Vi antigen is not involved coil F464, and its hybrid derivatives are protec-at all. S. typhi Ty2la is Vi negative (7; our own tive because of their expression of the S. typhi 0 observation). Nevertheless, when administered antigens.
as a live, oral vaccine, Ty2la has been shown to In previous studies with this system (1, (3) (4) (5) , be highly effective in protecting against typhoid we have repeatedly observed the inability of fever, both in human volunteers (7) and in a vaccination with the Vi antigen to influence recently concluded field trial that involved over protection against S. typhimurium hybrid H42 or 32,000 school children in Alexandria, Egypt (17. any other Vi-expressing S. typhimurium hybrid 18). Importantly, statistically significant protecchallenge organisms that we have examined.
tion is conferred by S. typhi Ty2la when the This has been the case regardless of whether the organism is grown under conditions in which its Vi antigen was administered to the animals 0 antigens are synthesized, but not when it is intraperitoneally (1, [3] [4] [5] or orally (3, 5). in grown under conditions in which its 0 antigens purified form (4. 5) or as a component of nonlivare not synthesized (7). Thus. in addition to ing vaccinating organisms (1), or, as in the showing that the Vi antigen is not required for present study, as a component of live vaccinatprotection, the behavior of this strain also indiing strains (3). Inasmuch as S. typhimuriumn cates the importance of the S. typhi 0 antigens hybrid H42 is also seen to be less discriminating in human typhoid immunization. as a challenge organism than S. typhimurium At the present time, the only example we hybrid HI, there seems to us no point in further know of in which the Vi antigen can clearly be employment of H42 for this purpose. Therefore, demonstrated to play a role in protective immusome consideration seems in order as to whether nization is the standard mouse assay system for using Vi-negative S. typhimurium hybrid HI as a typhoid vaccines, in which S. ,yphi. an obligate challenge organism in the present mouse assay human pathogen, is manipulated to serve. artifisybieem can, in fact, provide a valid indication of cially, as a challenge organism. Although artifithe potential of a vaccine for preventing typhoid ciality will always exist to some extent in any fever in humans, model system, our assay does utilize, we beWe pointed out earlier (4) that our use of S.
lieve. a somewhat more natural infection model. typhimurium hybrids expressing S. typhi antiin that the hybrid challenge strain is derived in line with those of human experience.
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